Horm Metab Res 2009; 41(3): 227-231
DOI: 10.1055/s-0028-1100412
Humans, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

Epicardial Adipose Tissue Adiponectin Expression is Related to Intracoronary Adiponectin Levels

G. Iacobellis 1 , C. R. Tiziana di Gioia 2 , D. Cotesta 3 , L. Petramala 3 , C. Travaglini 2 , V. De Santis 4 , D. Vitale 4 , L. Tritapepe 4 , C. Letizia 3
  • 1Department of Medicine, McMaster University, Hamilton, ON, Canada
  • 2Department of Experimental Medicine, Sapienza University, Rome, Italy
  • 3Department of Clinical Sciences, Sapienza University, Rome, Italy
  • 4Department of Anesthesiology and Intensive Care, Sapienza University, Rome, Italy
Further Information

Publication History

received 30.05.2008

accepted 25.09.2008

Publication Date:
10 November 2008 (online)

Abstract

The role of adiponectin and epicardial adipose tissue in coronary artery disease (CAD) is a subject of debate. Whether plasma adiponectin concentration in the coronary circulation is locally modulated by the epicardial fat is still unexplored. We evaluated the hypothesis whether intracoronary plasma adiponectin levels are related to adiponectin expression in epicardial adipose tissue in vivo in patients with CAD and without CAD (non-CAD). We examined 12 patients with CAD who required CABG and 10 patients with non-CAD who underwent cardiac surgery for valve replacement. Plasma levels of adiponectin were measured in peripheral vein circulation and in left coronary artery (LCA) during coronary angiography. Epicardial adipose tissue biopsy for adiponectin protein extraction was performed during cardiac surgery in both CAD and non-CAD subjects. Adiponectin protein expression in epicardial adipose tissue was lower in patients with CAD than in those with non-CAD (0.45±0.4 vs. 1.1±1.0, p<0.05). LCA plasma adiponectin levels significantly correlated with epicardial adipose tissue adiponectin protein expression (r=0.68, p=0.02) in all subjects. Peripheral adiponectin levels and epicardial fat adiponectin protein expression were the best correlates of LCA adiponectin, r2=0.49, p<0.01, p<0.05, respectively). Our study showed that intracoronary adiponectin levels reflect systemic adiponectin levels. Epicardial adipose tissue could partially contribute to adiponectin levels in the coronary circulation.

References

  • 1 Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart.  Nat Clin Pract Cardiovasc Med. 2005;  2 536-543
  • 2 Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ.  Horm Metab Res. 2008;  40 442-445
  • 3 Iacobellis G, Pond CM, Sharma AM. Adiposity of the heart.  Ann Intern Med. 2006;  145 554-555
  • 4 Sacks HS, Fain JN. Human epicardial adipose tissue: a review.  Am Heart J. 2007;  153 907-917
  • 5 Iacobellis G, Willens HJ, Barbaro G, Sharma AM. Threshold values of high-risk echocardiographic epicardial fat thickness.  Obesity (Silver Spring). 2008;  16 887-892
  • 6 Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, Gallo P, di Gioia CR. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease.  Cytokine. 2005;  29 251-255
  • 7 Ahn SG, Lim HS, Joe DY, Kang SJ, Choi BJ, Choi SY, Yoon MH, Hwang GS, Tahk SJ, Shin JH. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease.  Heart. 2008;  94(3) e7
  • 8 Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK, Rhee SJ, Lee EM, Lee J, Yoo NJ, Kim NH, Park JC. Echocardiographic epicardial fat thickness and coronary artery disease.  Circ J. 2007;  71 536-539
  • 9 Vos AM de, Prokop M, Roos CJ, Meijs MF, van der Schouw YT, Rutten A, Gorter PM, Cramer MJ, Doevendans PA, Rensing BJ, Bartelink ML, Velthuis BK, Mosterd A, Bots ML. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women.  Eur Heart J.. 2007;  29 777-783
  • 10 Iacobellis G, GaoYJ, Sharma AM. Do cardiac and perivascular adipose tissue play a role in atherosclerosis?.  Curr Diab Rep. 2008;  8 20-24
  • 11 Iacobellis G, Pellicelli AM, Sharma AM, Grisorio B, Barbarini G, Barbaro G. Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus.  Am J Cardiol. 2007;  99 1470-1472
  • 12 Chaowalit N, Somers VK, Pellikka PA, Rihal CS, Lopez-Jimenez F. Subepicardial adipose tissue and the presence and severity of coronary artery disease.  Atherosclerosis. 2006;  186 354-359
  • 13 Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, Voon WC, Sheu SH, Lai WT. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease.  Int J Obes (Lond). 2008;  32 268-274
  • 14 Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y. Human epicardial adipose tissue is a source of inflammatory mediators.  Circulation. 2003;  108 2460-2466
  • 15 Fain JN, Sacks HS, Buehrer B, Bahouth SW, Garrett E, Wolf RY, Carter RA, Tischansky DS, Madan AK. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots.  Int J Obes (Lond). 2008;  32 810-815
  • 16 Silaghi A, Achard V, Paulmyer-Lacroix O, Scridon T, Tassistro V, Duncea I, Clément K, Dutour A, Grino M. Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status.  Am J Physiol Endocrinol Metab. 2007;  293 E1443-1450
  • 17 Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova MG, Antonelli A. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease?.  Prog Brain Res. 2004;  146 279-289
  • 18 Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, McTernan PG. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.  Cardiovasc Diabetol. 2006;  5 1-7
  • 19 Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, Haluzikova D, Bosanska L, Vokurka M, Svacina S, Haluzik M. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance.  J Clin Endocrinol Metab. 2006;  91 4620-4627
  • 20 Date H, Imamura T, Ideguchi T, Kawagoe J, Sumi T, Masuyama H, Onitsuka H, Ishikawa T, Nagoshi T, Eto T. Adiponectin produced in coronary circulation regulates coronary flow reserve in nondiabetic patients with angiographically normal coronary arteries.  Clin Cardiol. 2006;  29 211-214
  • 21 Eyileten Z, Yilmaz MI, Kaya K, Akar AR, Kahraman D, Bingol S, Uysalel A, Ozyurda U. Coronary artery bypass grafting ameliorates the decreased plasma adiponectin level in atherosclerotic patients.  Tohoku J Exp Med.. 2007;  213 71-77
  • 22 Takano H, Kodama Y, Kitta Y, Nakamura T, Obata JE, Mende A. Transcardiac adiponectin gradient is independently related to endothelial vasomotor function in large and resistance coronary arteries in humans.  Am J Physiol Heart Circ Physiol. 2006;  291 H2641-H2646

Correspondence

Prof. G. IacobellisMD, PhD 

Department of Medicine

St. Joseph's Hospital

50 Charlton Avenue East Fontbonne Bldg

Hamilton

ON L8N 4A6

Canada

Phone: +1/905/521 11 55 327 39

Fax: +1/905/521 60 68

Email: gianluca@ccc.mcmaster.ca

    >